GURU.Markets stock price, segment price, and overall market index valuation
The company's share price NovaBay Pharmaceuticals
NovaBay, a biopharmaceutical company, shares reflect its transition from developing prescription drugs to selling over-the-counter eye and wound care products. The chart is a story of transformation and efforts to find its niche in the consumer market.
Share prices of companies in the market segment - Pharma eyes
NovaBay Pharmaceuticals is a pharmaceutical company that manufactures and markets eye and wound care products based on its proprietary technology. We've categorized it as a Pharma: Eye company. The chart below shows how investors value companies in the stable ophthalmology sector.
Broad Market Index - GURU.Markets
NovaBay Pharmaceuticals is a pharmaceutical company that manufactures and markets eye and wound care products. Its focus on this niche makes it a prominent player in the GURU.Markets index. The chart below represents the entire market. Find out how NovaBay shares compare to the overall market.
Change in the price of a company, segment, and market as a whole per day
NBY - Daily change in the company's share price NovaBay Pharmaceuticals
NovaBay Pharmaceuticals, Inc.'s daily stock price reflects volatility in the ophthalmology and wound care sector. This metric is a measure of the company's sensitivity to sales of its over-the-counter products and competition.
Daily change in the price of a set of shares in a market segment - Pharma eyes
NovaBay Pharmaceuticals specializes in ophthalmology drugs, and its volatility depends on sales and new developments. The chart below shows average daily fluctuations in this pharmaceutical segment. It helps assess how NBY's stock performance reflects its niche market.
Daily change in the price of a broad market stock, index - GURU.Markets
NovaBay Pharmaceuticals produces over-the-counter eye and wound care products. The company's stock price reflects consumer health trends and competition in the pharmacy market. These fluctuations are part of the overall picture of the consumer sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization NovaBay Pharmaceuticals
For NovaBay Pharmaceuticals, year-over-year performance tells the story of its eye and wound care products. Its market cap change over the past 12 months reflects the success of its flagship spray, Avenova. Its valuation is a bet on whether it can successfully compete with larger brands and expand its distribution network.
Annual dynamics of market capitalization of the market segment - Pharma eyes
NovaBay Pharmaceuticals, Inc. is a commercial pharmaceutical company specializing in eye and wound care products. This chart illustrates how its niche strategy, competition, and sales growth efforts impact its volatile performance in the pharmaceutical sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
NovaBay Pharmaceuticals, with its focus on personal care products, demonstrates how a small pharmaceutical company can compete in the consumer market. Its ability to outperform the market depends on brand strength and marketing effectiveness. This is a more stable story than risky biotechs.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization NovaBay Pharmaceuticals
NovaBay is a pharmaceutical company selling eye and wound care products. Its monthly performance reflects the commercial success of its flagship product, Avenova. Quarterly sales reports and distributor partnerships are key.
Monthly dynamics of market capitalization of the market segment - Pharma eyes
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the development and commercialization of eye and wound care products. The dynamics of its sector, shown in the chart, serve as background. It's interesting to assess how its flagship products, such as Avenova spray, compete in the over-the-counter ophthalmology and dermatology market.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
NovaBay Pharmaceuticals sells over-the-counter eye and wound care products. Its stock price is driven by sales volume and competition in the consumer market. The chart shows how the stock reacts to quarterly reports, making it more predictable than biotech companies, but still niche compared to the broader market.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization NovaBay Pharmaceuticals
NovaBay Pharmaceuticals produces antiseptic products for wound and eye care. Its weekly stock price is driven by sales volumes of its key products and competition in the pharmaceutical market.
Weekly dynamics of market capitalization of the market segment - Pharma eyes
NovaBay Pharmaceuticals specializes in ophthalmology and dermatology products. The chart compares the weekly performance of this niche company with the broader pharmaceutical sector. Does its niche allow it to chart a trajectory independent of industry trends?
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
NovaBay Pharmaceuticals is another biotech company whose stock exists in its own universe, reacting to clinical trial data. The chart clearly demonstrates how its weekly performance is isolated from general market fluctuations, following its own unique scientific trajectory.
Market capitalization of the company, segment and market as a whole
NBY - Market capitalization of the company NovaBay Pharmaceuticals
NovaBay Pharmaceuticals' market capitalization tells the story of finding a market niche for its product. The chart for this company, whose main product is an eyelid spray, shows how investors assess its ability to grow sales in the competitive over-the-counter market.
NBY - Share of the company's market capitalization NovaBay Pharmaceuticals within the market segment - Pharma eyes
NovaBay Pharmaceuticals specializes in the development and sale of antimicrobial products for eye and wound care. Its market capitalization in the ophthalmic pharmaceuticals segment reflects the commercial success of its flagship product, Avenova. The company's market capitalization is an indicator of its ability to compete in the over-the-counter market and expand the application of its technology.
Market capitalization of the market segment - Pharma eyes
NovaBay Pharmaceuticals produces antimicrobial eye and wound care products. How big is this niche? The chart below shows the overall market capitalization of the ophthalmology pharmaceutical sector. Its dynamics reflect the need for safe and effective products for everyday care and treatment.
Market capitalization of all companies included in a broad market index - GURU.Markets
The NovaBay Pharmaceuticals chart shows how the market values a company focused on eye and wound care products. Its market cap reflects its ability to successfully sell its over-the-counter products in a competitive market. This chart illustrates how a small brand struggles to gain shelf space.
Book value capitalization of the company, segment and market as a whole
NBY - Book value capitalization of the company NovaBay Pharmaceuticals
For NovaBay Pharmaceuticals, which specializes in eye and wound care products, book value is its tangible assets: brand rights (Avenova), product inventory, and commercial infrastructure. The chart below shows how the value of this tangible foundation has changed.
NBY - Share of the company's book capitalization NovaBay Pharmaceuticals within the market segment - Pharma eyes
NovaBay Pharmaceuticals, Inc. is a pharmaceutical company whose assets include manufacturing facilities for its proprietary eye and wound care products. The chart shows the share of this specialized commercial pharmaceutical infrastructure the company controls in its niches.
Market segment balance sheet capitalization - Pharma eyes
NovaBay Pharmaceuticals is a biopharmaceutical company. Pharmaceuticals, as the chart shows, are both knowledge- and capital-intensive. As a commercial company, NovaBay invests not only in R&D but also in the infrastructure to market its products.
Book value of all companies included in the broad market index - GURU.Markets
NovaBay's assets are not its factories, but rather its brand and commercial infrastructure for selling its hypochlorous acid-based products, such as Avenova eyelid spray. Its book value reflects its operational capabilities and the value of its brand in the marketplace.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - NovaBay Pharmaceuticals
NovaBay Pharmaceuticals sells over-the-counter eye and wound care products. Its value lies in its Avenova brand. The chart shows how the market views its commercial efforts and its ability to compete with larger players.
Market to book capitalization ratio in a market segment - Pharma eyes
NovaBay Pharmaceuticals develops and markets eye and wound care products. The chart shows how the market values its commercialized products (Avenova) and their market share relative to its operating and manufacturing assets.
Market to book capitalization ratio for the market as a whole
NovaBay Pharmaceuticals sells ophthalmology and dermatology products. Its brand and patents for its core technology, Avenova, are key intangible assets. This chart helps understand how the market values niche pharmaceutical companies with commercialized products.
Debts of the company, segment and market as a whole
NBY - Company debts NovaBay Pharmaceuticals
NovaBay Pharmaceuticals develops and markets antimicrobial products for wound and eye care. Commercializing these medical products requires capital for marketing to physicians and consumers, as well as inventory management. This chart illustrates how the company finances its sales and distribution expansion efforts in a competitive market.
Market segment debts - Pharma eyes
NovaBay Pharmaceuticals is a pharmaceutical company that manufactures and markets eye and wound care products. Unlike biotechs in the R&D stage, it has revenue but also incurs marketing expenses. This chart shows how it balances commercial activities and R&D.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio NovaBay Pharmaceuticals
NovaBay Pharmaceuticals sells ophthalmology and dermatology products. This chart shows its financial structure. For a small pharmaceutical company competing with giants, financial flexibility is essential. High debt can limit the marketing funds needed to promote its brands.
Market segment debt to market segment book capitalization - Pharma eyes
NovaBay Pharmaceuticals specializes in developing antimicrobial products for wound, eye, and skin care. This market is competitive. The chart shows the overall debt burden in the pharmaceutical industry, which helps assess how the company finances the commercialization of its niche but important healthcare products.
Debt to book value of all companies in the market
NovaBay Pharmaceuticals is a pharmaceutical company selling eye and wound care products. Unlike R&D biotechs, it has revenue but can use debt for marketing. This chart provides context for assessing how aggressively the company uses leverage to grow sales of its commercial products.
P/E of the company, segment and market as a whole
P/E - NovaBay Pharmaceuticals
This metric for NovaBay Pharmaceuticals, a company that produces antiseptic products, measures its commercial performance. The P/E reflects sales of its sprays and wipes. It's the valuation of a niche player in the personal care market whose profitability depends on brand strength and distribution.
P/E of the market segment - Pharma eyes
NovaBay Pharmaceuticals is a biopharmaceutical company that develops and markets eye care (Avenova) and wound care products based on its proprietary technology. This chart shows the average market value for the sector, helping to understand how the market values NovaBay's niche products.
P/E of the market as a whole
NovaBay Pharmaceuticals is a pharmaceutical company specializing in anti-infective wound and eye care products. Its valuation depends on the commercial success of its products. General market sentiment, reflected in this chart, has little impact on its business, which is determined by the specifics of its niche market and competition.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company that develops and markets eye and wound care products. This chart reflects sales expectations for its flagship product, Avenova. Future profitability depends on its success in the over-the-counter market and the company's ability to compete effectively.
%20P%2FE%20NovaBay%20Pharmaceuticals&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-NovaBay-Pharmaceuticals&v=1772668737288 "Chart of the company's future (projected) P/E NovaBay Pharmaceuticals")
Future (projected) P/E of the market segment - Pharma eyes
NovaBay Pharmaceuticals specializes in commercializing eye care products, such as Avenova spray. Its valuation relative to other pharmaceutical companies reflects investor sentiment about its niche products, demonstrating how the market views its ability to compete in the over-the-counter ophthalmic market.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20eyes&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-eyes&v=1772668737324 "Future (projected) P/E graph of the market segment - Pharma eyes")
Future (projected) P/E of the market as a whole
NovaBay Pharmaceuticals develops and markets eye and wound care products. It's a company with commercial products, but it's also pursuing R&D. This chart reflects overall sentiment in the healthcare sector. It helps assess investor sentiment toward smaller pharmaceutical companies that are trying to grow through both sales and innovation.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772668737360 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company commercializing eye and wound care products. Its financial results, presented here, are dependent on successful sales of its flagship product, Avenova, and competition in the over-the-counter ophthalmic market.
Profit of companies in the market segment - Pharma eyes
NovaBay Pharmaceuticals specializes in developing antimicrobial products for wound care and ophthalmology. This chart shows the overall profitability of the ophthalmic pharmaceutical sector. It helps understand the size and profitability of the market for maintenance therapy and over-the-counter products in this area.
Overall market profit
NovaBay Pharmaceuticals specializes in commercializing eye and wound care products. Its success depends on effective marketing and distribution. This business is less dependent on general economic cycles, as reflected in this chart, and more dependent on competition and consumer preferences within its niche.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company NovaBay Pharmaceuticals
NovaBay Pharmaceuticals develops and markets ophthalmology and dermatology products. The company's future profitability depends on sales of its key brands. This chart reflects analyst expectations for demand for its eye and skin care products and its ability to compete in these markets.
%20profit%20of%20the%20company%20NovaBay%20Pharmaceuticals&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-NovaBay-Pharmaceuticals&v=1772668737484 "Graph of future (projected) profit of the company NovaBay Pharmaceuticals")
Future (predicted) profit of companies in the market segment - Pharma eyes
NovaBay Pharmaceuticals is a pharmaceutical company that develops and markets eye and wound care products. Their key product uses hypochlorous acid, which has antimicrobial properties. This chart shows forecasts for the ophthalmic pharmaceutical industry. It helps assess how a company with niche products competes in the larger care market.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20eyes&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-eyes&v=1772668737503 "Graph of future (predicted) profits of companies in a market segment - Pharma eyes")
Future (predicted) profit of the market as a whole
This chart illustrates consumer spending on healthcare. NovaBay Pharmaceuticals, a manufacturer of over-the-counter ophthalmic products, depends on people's willingness to spend on their health. Rising incomes support demand, while economic uncertainty may force people to seek cheaper alternatives.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772668737558 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - NovaBay Pharmaceuticals
NovaBay Pharmaceuticals sells over-the-counter eye and wound care products. This chart shows how the market views its current sales and its ability to compete in the consumer healthcare market.
P/S market segment - Pharma eyes
NovaBay Pharmaceuticals is a pharmaceutical company specializing in the development and sale of antimicrobial products for wound, eye, and skin care. This chart shows the average valuation in the ophthalmology sector. It helps understand how investors view NovaBay's niche products and their position in the personal care market.
P/S of the market as a whole
NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that develops and markets eye and wound care products. Its primary product is an eyelid hygiene spray. Revenue is driven by sales of these over-the-counter products. This chart helps assess market sentiment for the company's niche consumer health products.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company NovaBay Pharmaceuticals
NovaBay Pharmaceuticals specializes in commercializing eye and wound care products. Future revenue depends on the successful sales of its core product, Avenova. This chart shows how investors assess its ability to compete in the ophthalmology and dermatology markets.
%20P%2FS%20NovaBay%20Pharmaceuticals&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-NovaBay-Pharmaceuticals&v=1772668737666 "The graph of the company's future (projected) P/S NovaBay Pharmaceuticals")
Future (projected) P/S of the market segment - Pharma eyes
NovaBay Pharmaceuticals is a pharmaceutical company that manufactures and markets eye and wound care products based on its proprietary Avenova technology. This chart shows how the market estimates its future sales of niche medical products compared to other pharmaceutical companies.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20eyes&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-eyes&v=1772668737689 "Future (projected) P/S market segment graph - Pharma eyes")
Future (projected) P/S of the market as a whole
This chart illustrates investor sentiment in the pharmaceutical sector. For NovaBay Pharmaceuticals, a company that produces antiseptic eye and wound care products, this indicates stable demand. Market optimism may impact consumer spending, but the demand for quality hygiene products remains high.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772668737694 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a pharmaceutical company that develops and markets eye and wound care products. Its flagship product is Avenova spray. This chart shows revenue from online and distributor sales. Sales growth reflects demand for eyelid hygiene and dry eye treatments.
Sales of companies in the market segment - Pharma eyes
NovaBay Pharmaceuticals is a biopharmaceutical company specializing in the development and marketing of eye and wound care products. This chart shows the dynamics of the ophthalmic pharmaceutical sector. The company's flagship product, Avenova, is an example of an effective and safe eyelid hygiene product, occupying an important market niche.
Overall market sales
NovaBay Pharmaceuticals is a pharmaceutical company specializing in eye care products. Its sales are driven by consumer demand and physician recommendations. This general economic activity chart reflects the purchasing power of the population, which influences sales of over-the-counter medical products.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company NovaBay Pharmaceuticals
NovaBay Pharmaceuticals specializes in commercializing eye care products, specifically hypochlorous acid-based eye sprays. This chart shows analysts' forecasts for the growth of the over-the-counter ophthalmic product market and demand for the company's products.
%20sales%20of%20the%20company%20NovaBay%20Pharmaceuticals&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-NovaBay-Pharmaceuticals&v=1772668737815 "Schedule of future (projected) sales of the company NovaBay Pharmaceuticals")
Future (projected) sales of companies in the market segment - Pharma eyes
NovaBay Pharmaceuticals develops and markets eye and wound care products. This chart shows expectations for the pharmaceutical sector, focused on ophthalmology. It reflects the stable demand for effective and safe treatments for common eye diseases.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20eyes&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-eyes&v=1772668737862 "Schedule of future (projected) sales of companies in the market segment - Pharma eyes")
Future (projected) sales of the market as a whole
NovaBay Pharmaceuticals, Inc. is a pharmaceutical company specializing in the commercialization of eye and wound care products. Its success depends on effective sales in pharmacies and online. This chart, reflecting overall consumer spending on health, is an indicator of how actively people are purchasing over-the-counter personal care products.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772668737917 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality NovaBay Pharmaceuticals
NovaBay Pharmaceuticals sells over-the-counter eye and wound care products. This chart shows profitability in the consumer healthcare sector. Profit is driven by sales of its flagship product, Avenova, and the effectiveness of marketing campaigns targeting both physicians and consumers.
Market segment marginality - Pharma eyes
NovaBay Pharmaceuticals specializes in the development and commercialization of eye and wound care products. Profitability in this field depends on product effectiveness and marketing strategy. This chart shows average profitability in the pharmaceutical industry, allowing one to assess how successfully the company competes in the market and promotes its brands.
Market marginality as a whole
NovaBay Pharmaceuticals specializes in the commercialization of antimicrobial products for eye and wound care. This total market profitability chart does not directly impact the company. Demand for its products is driven by medical need. Its margins depend on marketing effectiveness, competition, and sales volume.
Employees in the company, segment and market as a whole
Number of employees in the company NovaBay Pharmaceuticals
NovaBay Pharmaceuticals sells over-the-counter eye and skin care products. This chart shows a small sales team. Following a restructuring and refocus, the company now operates with a lean staff focused on marketing and sales of its key brands.
Share of the company's employees NovaBay Pharmaceuticals within the market segment - Pharma eyes
NovaBay Pharmaceuticals develops and markets antimicrobial products for wound and eye care. This chart shows the percentage of chemists, microbiologists, and sales professionals the company attracts in its niche. It reflects its operational scale and ability to market and commercialize its specialized medical products.
Number of employees in the market segment - Pharma eyes
NovaBay Pharmaceuticals specializes in developing antimicrobial products, particularly for eye and wound care. This chart demonstrates that there's room in the pharmaceutical industry for niche players who focus on specific problems and create effective solutions that require a team of chemists, microbiologists, and marketing specialists.
Number of employees in the market as a whole
NovaBay Pharmaceuticals specializes in ophthalmology products, a narrow but important niche in the pharmaceutical industry. The presence of numerous such specialized companies speaks to the maturity and depth of the market. This total employment chart includes these niche segments, which collectively create a significant number of jobs.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company NovaBay Pharmaceuticals (NBY)
NovaBay Pharmaceuticals is a pharmaceutical company specializing in eye care products (Avenova). This chart reflects the value of its "intellectual capital." Its primary asset is not its manufacturing facilities, but its patented formula (Neutrox) and the Avenova brand. The chart shows how the market values this brand and its ability to generate sales per employee.
%20of%20the%20company%20NovaBay%20Pharmaceuticals%20(NBY)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-NovaBay-Pharmaceuticals-NBY&v=1772668738381 "Chart of market capitalization per employee (in thousands of dollars) of the company NovaBay Pharmaceuticals (NBY)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma eyes
NovaBay Pharmaceuticals develops antimicrobial products for eye and wound care. This is a niche but stable market. The chart shows how the market values their product portfolio and commercial team. Comparison with the sector helps understand how effectively they are monetizing their scientific foundation.
%20by%20market%20segment%20-%20Pharma%20eyes&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-eyes&v=1772668738401 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma eyes")
Market capitalization per employee (in thousands of dollars) for the overall market
NovaBay Pharmaceuticals is a pharmaceutical company specializing in eye and wound care products. This chart shows the market average per-employee value, which helps evaluate the company with commercialized products.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772668738462 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company NovaBay Pharmaceuticals (NBY)
NovaBay Pharmaceuticals is a company with commercial products (such as Avenova for eyelid hygiene). This chart shows how efficiently their small team generates sales revenue. It reflects the margins of their niche ophthalmic products.
%20Chart%20NovaBay%20Pharmaceuticals%20(NBY)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-NovaBay-Pharmaceuticals-NBY&v=1772668738496 "Company Profit Per Employee (in thousands of dollars) Chart NovaBay Pharmaceuticals (NBY)")
Profit per employee (in thousands of dollars) in the market segment - Pharma eyes
NovaBay Pharmaceuticals is a pharmaceutical company that develops and markets eye and wound care products. Its business model combines marketing of existing products with the development of new ones. This chart helps evaluate how effectively the commercial division generates revenue, which in turn funds further research and development.
%20in%20the%20market%20segment%20-%20Pharma%20eyes&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-eyes&v=1772668738506 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma eyes")
Profit per employee (in thousands of dollars) for the market as a whole
NovaBay Pharmaceuticals (NBY) is a biopharmaceutical company commercializing eye care products (Avenova eyelid spray) and wound care. This includes R&D and commercialization. This chart shows the market-standard profitability per employee. It helps assess how effectively NBY utilizes its commercial and R&D staff to generate revenue from its product portfolio.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772668738559 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee NovaBay Pharmaceuticals (NBY)
NovaBay Pharmaceuticals is a pharmaceutical company specializing in eye care products. This chart shows the company's success in commercializing niche medical products. It reflects how successfully it sells its brands, such as Avenova, through pharmacies and online channels.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-NovaBay-Pharmaceuticals-NBY&v=1772668738568 "Sales chart per company employee NovaBay Pharmaceuticals (NBY)")
Sales per employee in the market segment - Pharma eyes
NovaBay Pharmaceuticals is a commercial pharmaceutical company focused on eye care (Avenova) and wound care products. This is a niche market. This chart shows the average revenue per employee in this segment. It helps assess how efficiently NovaBay's compact team monetizes its products compared to other pharmaceutical companies.
Sales per employee for the market as a whole
NovaBay Pharmaceuticals is a pharmaceutical company commercializing eye care products (Avenova) and wound care. It's a B2C/B2B business. This chart shows how efficiently their small sales team generates revenue from sales of their niche, yet high-margin products.
Short shares by company, segment and market as a whole
Shares shorted by company NovaBay Pharmaceuticals (NBY)
NovaBay Pharmaceuticals is a company whose main product is Avenova, an eyelid hygiene spray. It's a niche and competitive market. This chart shows the bets that the company won't be able to grow. "Bears" believe their product has little potential, and attempts to expand into other markets (such as cosmetics) have failed.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-NovaBay-Pharmaceuticals-NBY&v=1772668738706 "Short Shares Chart for the Company NovaBay Pharmaceuticals (NBY)")
Shares shorted by market segment - Pharma eyes
NovaBay Pharmaceuticals (NBY) is a biopharmaceutical company whose main product is Avenova, an eyelid hygiene spray used to treat blepharitis and dry eyes. This chart shows the total short position in the ophthalmology biotech sector. The high figure reflects general investor skepticism about the commercial success of niche products in this space.
Shares shorted by the overall market
NovaBay Pharmaceuticals sells over-the-counter products, primarily eye care sprays (Avenova). This chart measures overall fear. Although their products are consumer goods, NBY is a small company struggling to achieve profitability. When investors are afraid, they worry that NBY won't have enough marketing funds to compete with the pharmacy giants.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator NovaBay Pharmaceuticals (NBY)
NovaBay Pharmaceuticals sells over-the-counter products, primarily Avenova, an eyelid spray. This is a niche consumer market. This indicator shows how investors react to quarterly sales reports, indicating "overbought" (above 70) when the stock is growing or "oversold" (below 30) when competition is intensifying.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-NovaBay-Pharmaceuticals-NBY&v=1772668738741 "RSI 14 indicator chart for the company's stock NovaBay Pharmaceuticals (NBY)")
RSI 14 Market Segment - Pharma eyes
NovaBay Pharmaceuticals is a biopharmaceutical company specializing in the development of antimicrobial drugs. Their main product is Avenova, a spray for the treatment of eyelid hygiene (blepharitis). This chart measures the overall momentum in the ophthalmic biotech sector. It helps differentiate NBY's movement from the overall industry trend.
RSI 14 for the overall market
For NovaBay Pharmaceuticals, a biotech in R&D, this chart is a lifeline showing capital availability. During moments of market euphoria, investors are willing to "buy the dream" and fund breakthrough but risky research. When the market panics, the money supply is shut off, and cash-burning companies face a liquidity crisis.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast NBY (NovaBay Pharmaceuticals)
NovaBay Pharmaceuticals specializes in commercializing eye care products, primarily Avenova spray for the treatment of blepharitis. This chart shows the average analyst forecast. Their targets are based on growth in Avenova sales (via prescriptions and online) and the success of their other products.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-NBY-NovaBay-Pharmaceuticals&v=1772668738841 "A chart showing analyst consensus forecasts for the expected stock price. NBY (NovaBay Pharmaceuticals)")
The difference between the consensus estimate and the actual stock price NBY (NovaBay Pharmaceuticals)
NovaBay Pharmaceuticals specializes in antimicrobial products. Its flagship product is Avenova, an eyelid hygiene spray used to treat blepharitis. This chart measures the gap between the current price and the consensus target price. It shows whether experts believe this niche ophthalmology product will be commercially successful.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-NBY-NovaBay-Pharmaceuticals&v=1772668738860 "A chart showing the difference between the consensus forecast and the actual stock price. NBY (NovaBay Pharmaceuticals)")
Analyst consensus forecast for stock prices by market segment - Pharma eyes
NovaBay (NBY) is a pharmaceutical company focused on eye health. Its flagship product (Avenova) is a spray for the treatment of blepharitis and eyelid hygiene. This chart reflects analysts' overall expectations for the entire ophthalmic pharmaceutical sector. It shows whether experts believe this niche market will grow or whether they consider it overcrowded.
Analysts' consensus forecast for the overall market share price
NovaBay (NBY) is a company that produces "super antiseptic." Their key product (Avenova) is a hypochlorous acid-based spray for eyelid hygiene, which is also used to treat wounds. This chart shows the overall sentiment of experts. It reflects the analysts' confidence in the stability of consumer spending on wellness and health products.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index NovaBay Pharmaceuticals
NovaBay is a boutique pharmaceutical company. Their signature product is Avenova, a hypochlorous acid-based spray that is the gold standard for eyelid hygiene for dry eyes and blepharitis. This chart is a summary indicator of their single-brand operation. It reflects their ability to monetize this niche but sticky product and their reliance on direct-to-consumer marketing.
AKIMA Market Segment Index - Pharma eyes
NovaBay (NBY) is a pharmaceutical company focused on commercialization. Their flagship product is Avenova, a hypochlorous acid-based spray for eyelid hygiene (treatment of blepharitis). This chart shows the segment average index. It helps investors assess how well NovaBay is selling its niche ophthalmology product compared to the average.
The AKIM Index for the overall market
NovaBay Pharmaceuticals is a biopharmaceutical company that sells Avenova, an eyelid and eyelash cleanser. This chart, which reflects the market average, provides a macro backdrop. It helps assess how this niche business stacks up against overall economic trends and consumer spending.
